<DOC>
	<DOCNO>NCT02751710</DOCNO>
	<brief_summary>This trial conduct determine impact whole body FDG PET-CT vs. conventional staging management patient present clinical Stage III breast cancer . Eligible consent patient ductal mixed histology breast cancer randomize 1:1 whole body FDG PET-CT conventional staging . Eligible consent patient lobular histology enter separate single arm prospective study undergo whole body FDG PET-CT , CT contrast chest/abdomen &amp; pelvis bone scan .</brief_summary>
	<brief_title>Impact 18F-FDG PET-CT Versus Conventional Staging Management Patients Presenting With Clinical Stage III Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Women ( men ) histological evidence breast cancer potentially curative treatment plan . Based clinical information ( physical exam , image ) : 1 . Stage III breast cancer ( T0N2 , T1N2 , T2N2 , T3N1 , 2 T4 ) , 2 . Stage IIb breast cancer ( T3N0 ) , Note : T2N1 eligible Considered combine modality therapy ( surgical resection , chemotherapy , radiotherapy ) curative intent . Age &lt; 18 year , ECOG performance status &gt; = 3 , Prior systemic therapy ( e.g . neoadjuvant chemotherapy hormonal therapy ) current breast cancer , Previous stag investigation current breast cancer , Breast cancer primary histological subtypes ductal lobular ( Note : Patients mixed disease eligible randomization ) , Clinical suspicion metastatic disease , Relative contraindication PET ( e.g . uncontrolled diabetes ( i.e . inability decrease serum glucose 10.2 mmol/L ) , claustrophobia , inability still 30 minute ) , Inability lie supine imaging PETCT , Inability undergo CT know allergy contrast , History another invasive malignancy within previous two year ( exception non melanoma skin cancer ) synchronous primary cancer , include synchronous contralateral breast cancer ( Note : Patients find contralateral breast cancer study image follow randomization remain study ) , Known pregnancy lactate female , Inability complete study require followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>